Abstract

Advances in medical technology have made intrathecal baclofen therapy a suitable treatment option for patients suffering from a variety of disorders affecting movement, especially spasticity. These patients have typically exhausted conservative therapies, usually including oral baclofen therapy which has either failed to result in clinically significant reductions in spasticity, intolerable baclofen-related side effects (i.e., sedation), or both. Intrathecal drug delivery systems for movement disorders can provide continuous infusions of baclofen for improvement in rigidity and/or spasticity.

Original languageEnglish (US)
Title of host publicationDeer's Treatment of Pain
Subtitle of host publicationAn Illustrated Guide for Practitioners
PublisherSpringer Science+Business Media
Pages691-697
Number of pages7
ISBN (Electronic)9783030122812
ISBN (Print)9783030122805
DOIs
StatePublished - Jan 1 2019

All Science Journal Classification (ASJC) codes

  • General Medicine
  • General Neuroscience

Fingerprint

Dive into the research topics of 'IDDS for Movement Disorders'. Together they form a unique fingerprint.

Cite this